JPMorgan placed Primo Brands (PRMB) on “Positive Catalyst Watch” while keeping an Overweight rating on the name with a $33 price target The Q4 earnings and analyst day the week following ...
Shares of Catalyst Pharmaceuticals rose as the company reached a settlement agreement with Teva Pharmaceuticals related to Teva's plans for a generic version of Firdapse 10 mg tablets. Catalyst stock ...
Some results have been hidden because they may be inaccessible to you